Indole Compounds Against Breast Cancer: Recent Developments

Author(s): Bernhard Biersack, Rainer Schobert

Journal Name: Current Drug Targets

Volume 13 , Issue 14 , 2012

Become EABM
Become Reviewer


Breast cancer is still the leading cause of cancer deaths among women worldwide and new therapies and drugs are continuously being conceived and explored to better control or even cure this disease. Among the most efficacious low-molecular drugs for the treatment of breast cancer are indole derivatives such as 3,3’-diindolylmethane (DIM), the structurally complex antimitotic vinca alkaloids, and the synthetic receptor tyrosine kinase inhibitor sunitinib. This review is to give an insight into the latest developments in the field of indole based drugs against breast cancers with a focus on those derived from natural products and on their targets and modes of action. Pertinent literature is covered from 2007 up to 2012.

Keywords: Indole, DIM, kinase inhibitors, protein binders, tubulin, anticancer drugs, breast cancer

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [1705 - 1719]
Pages: 15
DOI: 10.2174/138945012804545551
Price: $65

Article Metrics

PDF: 23